Navigation Links
Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
Date:7/11/2013

Poway, California (PRWEB) July 11, 2013

Vet-Stem, Inc. is proud to announce the addition of Erwin F. Workman, Jr., PhD, to their Board of Directors. Dr. Workman has over 35 years of successful diagnostic and scientific development experience with IDEXX Laboratories, Inc. (IDXX) and Abbott Laboratories, Inc. (ABT). Dr. Workman’s successes in Research and Development, Business Operations, Manufacturing and Distribution while at IDEXX Laboratories, Inc. are a good marriage with Vet-Stem, Inc.’s decade of development in the field of Regenerative Veterinary Medicine.

Dr. Workman was a key participant in the creation of the world’s largest veterinary diagnostic company, IDEXX Laboratories, Inc. Dr. Workman helped lead IDEXX Laboratories, Inc. through startup, new product development, initial profitability, global expansion and a successful IPO.

Prior to joining IDEXX Laboratories, Inc. Dr. Workman oversaw and directed the Research and Development of the Hepatitis and AIDS business unit of Abbott Laboratories, Inc.

“Dr. Workman will bring many years of proven experience to the Board of Directors, while helping guide Vet-Stem to become a global leader in Regenerative Veterinary Medicine. IDEXX Laboratories, Inc. encountered many of the same growth and new product development challenges facing Vet-Stem, Inc. today. I am proud to have Dr. Workman as a trusted advisor during this phase of rapid expansion and new product development,” states Robert Harman, DVM, CEO and Founder of Vet-Stem, Inc.

“It is a privilege to be associated with the Vet-Stem management team and their exciting and proprietary stem cell technology,” says Dr. Workman. “Vet-Stem has been a pioneer in the field of regenerative medicine for animals and has extensive laboratory and clinical experience with adipose tissue-derived stem cells. The use of these cells offers tremendous therapeutic potential and could revolutionize the way veterinarians treat injuries or disease states where control of pain and regeneration of healthy tissue is crucial.”

Dr. Workman’s position on the Board of Directors for Vet-Stem will serve the purpose of leading strategic planning and execution for current and future services and products. He will compliment the other board members that represent the venture capital perspective (Linda Powers), multi-national agribusiness (Dr. Mike McCloskey), and biotechnology operations and distribution (Mike Dale).    

Vet-Stem, Inc. developed and owns patents for fat-derived stem cell veterinary technology to isolate stem and regenerative cells from the animal’s own fat for therapeutic injection into injured areas. Over the last ten years Vet-Stem, Inc.’s lab has provided stem cell services for treatment of more than 10,000 dogs, cats, and horses in the US and Canada.

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10917385.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
2. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
3. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
4. Utah, There is No Better Place U.S. Chamber of Commerce Ranks Utah as the Top Performer in the Nation
5. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
6. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
7. Non-Intrusive Black Mold Removal Procedure Released By Former Mold Remediation Specialist, MyCleaningProducts.com Explains
8. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
9. Former Stryker CEO Takes Reins at sBioMed
10. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
11. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Ky. , Feb. 10, 2016 NX ... utilizing its proprietary NeXosome® technology for early warning ... of its most recent study by Dr. ... at the Society for Maternal Fetal Medicine,s (SMFM) annual ... GA, February 1-6 th , 2016.  The presentation reported ...
(Date:2/10/2016)...  Allergan plc (NYSE: AGN ) a leading ... , Allergan,s CEO and President, will be featured as ... the RBC Capital Markets Healthcare Conference on Tuesday, February ... York Palace Hotel in New York, NY ... can be accessed on Allergan,s Investor Relations web site ...
(Date:2/10/2016)... NY (PRWEB) , ... February 10, 2016 , ... LATHAM, ... packages at the SPIE Photonics West conference in San Francisco’s Moscone Center ... 14 in the same venue. , These latest InGaAs PIN diode standard packages ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... regenerative medicine, has announced a new agreement with Singapore-based Global Stem Cells Network ... from the Philippines, Thailand and Singapore in the latest adipose and bone marrow ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:1/27/2016)...  Rite Track, Inc. a leading semiconductor equipment and ... Ohio announced today the acquisition of PLUS LLC. ... Austin, Texas , will significantly bolster ... installations and technical support offerings for TEL Track Systems. ... "PLUS has provided world class service including refurbishment, enhancements ...
Breaking Biology News(10 mins):